Sándor L. Bekö, Edith Alig, Martin U. Schmidt, Jacco van de Streek (2014): "On the correlation between hydrogen bonding and melting points in the inositols". International Union of Crystallography Journal (IUCrJ), volume 1, part 1, pages 61-73. doi:10.1107/S2052252513026511
William R. Sherman, Mark A. Stewart, Mary M. Kurien, Sally L. Goodwin (1968): "The measurement of myo-inositol, myo-inosose-2 and scyllo-inositol in mammalian tissues". Biochimica et Biophysica Acta (BBA), volume 158, issue 2, pages 197-205 doi:10.1016/0304-4165(68)90131-1
William H. Horner, I.H. Thaker (1968): "The metabolism of scyllo-inositol in Streptomyces griseus". Biochimica et Biophysica Acta (BBA), volume 165, issue 2, pages 306-308 doi:10.1016/0304-4165(68)90064-0
Trevor A Thorpe, C Stasolla, Edward Yeung, Geert-Jan De Klerk, A. Roberts, E.F. George (2008): "The components of plant tissue culture media II. Organic additions, osmotic and pH effects, and support systems". In Plant Propagation by Tissue Culture, 3rd edition, pages 115–173. doi:10.1007/978-1-4020-5005-3_4
Graeme M. Day, Jacco van de Streek, Arnaud Bonnet, Jonathan C. Burley, William Jones, and W. D. Sam Motherwell (2006): "Polymorphism of scyllo-inositol: Joining crystal structure prediction with experiment to elucidate the structures of two polymorphs". Crystal Growth & Design, volume 6, issue 10, pages 2301-2307. doi:10.1021/cg060179a
Sung-Kee Chung, Yong-Uk Kwon, Young-Tae Chang, Kwang-Hoon Sohn, Jung-Han Shin, Kyu-Hwan Park, Bong-Jin Hong, In-Hee Chung (1999): "Synthesis of all possible regioisomers of scyllo-Inositol phosphate". Bioorganic & Medicinal Chemistry, volume 7, issue 11, pages 2577-2589 doi:10.1016/S0968-0896(99)00183-2
Alexandra Simperler, Stephen W. Watt, P. Arnaud Bonnet, William Jones, W. D. Samuel Motherwell (2006): "Correlation of melting points of inositols with hydrogen bonding patterns". CrystEngComm, volume 8, pages 589-600 doi:10.1039/B606107A
Michael Podeschwa, Oliver Plettenburg, Jochen vom Brocke, Oliver Block, Stephan Adelt, Hans-Josef Altenbach (2003): "Stereoselective synthesis of myo-, neo-, L-chiro, D-chiro, allo-, scyllo-, and epi-inositol systems via conduritols prepared from p-benzoquinone". European Journal of Organic Chemistry, volume 2003, issue 10, pages 1958-1972. doi:10.1002/ejoc.200200572
Joseph Bruton, William H. Horner, Gerald A. Russ (1967): "Biosynthesis of streptomycin: IV. Further studies on the biosynthesis of streptidine and N-methyl-L-glucosamine". Journal of Biological Chemistry, volume 242, issue 5, 10 March, pages 813-818 doi:10.1016/S0021-9258(18)96198-3
Tetsuro Morinaga, Hitoshi Ashida and Ken-ichi Yoshida (2010): "Identification of two scyllo-inositol dehydrogenases in Bacillus subtilis". Microbiology, volume 156, issue 5, pages 1538–1546 doi:10.1099/mic.0.037499-0
Masaru Yamaoka, Shin Osawa, Tetsuro Morinaga, Shinji Takenaka, Ken-ichi Yoshida (2011): "A cell factory of Bacillus subtilis engineered for the simple bioconversion of myo-inositol to scyllo-inositol, a potential therapeutic agent for Alzheimer's disease". Microbial Cell Factories, volume 10, article number 69. doi:10.1186/1475-2859-10-69
Kosei Tanaka, Ayane Natsume, Shu Ishikawa, Shinji Takenaka, Ken-ichi Yoshida (2017): "A new-generation of Bacillus subtilis cell factory for further elevated scyllo-inositol production". Microbial Cell Factories, volume 16, article number 67. doi:10.1186/s12934-017-0682-0,
Paul Ramp, Alexander Lehnert, Susana Matamouros, Astrid Wirtz, Meike Baumgart, Michael Bott (2021): "Metabolic engineering of Corynebacterium glutamicum for production of scyllo-inositol, a drug candidate against Alzheimer's disease". Metabolic Engineering, volume 67, pages 173-185 doi:10.1016/j.ymben.2021.06.011
Hyo Won Lee and Yoshito Kishi (1985): "Synthesis of mono- and unsymmetrical bis-orthoesters of scyllo-inositol". Journal of Organic Chemistry, volume 50, issue 22, pages 4402–4404 doi:10.1021/jo00222a046
Lief Skøt, Helge Egsgaard (1984): "Identification of ononitol and O-methyl-scyllo-inositol in pea root nodules". Planta, volume 161, pages 32–36. doi:10.1007/BF00951457
Benjamin L. Turner, Alan E. Richardson (2004): "Identification of scyllo-inositol phosphates in soil by solution phosphorus-31 nuclear magnetic resonance spectroscopy". Soil Science Society of America Journal, division S-2 Soil Chemistry, volume 68, issue 3 pages 802-808. doi:10.2136/sssaj2004.8020
Benjamin L. Turner, Nathalie Mahieu, Leo M. Condron, C. R. Chen (2005): "Quantification and bioavailability of scyllo-inositol hexakisphosphate in pasture soils". Soil Biology and Biochemistry, volume 37, issue 11, pages 2155-2158 doi:10.1016/j.soilbio.2005.03.005
Thomas Michaelis, Gunther Helms, Klaus-Dietmar Merboldt, Wolfgang Hänicke, Harald Bruhn, Jens Frahm (1993): "Identification of scyllo-inositol in proton NMR spectra of human brain in vivo". NMR in Biomedicine, volume 6, issue 1, pages 105-109. doi:10.1002/nbm.1940060116
Lana G. Kaiser, Norbert Schuff, Nathan Cashdollar, Michael W. Weiner (2005): "Scyllo-inositol in normal aging human brain: 1H magnetic resonance spectroscopy study at 4 Tesla". NMR in Biomedicine, volume 18, issue 1, pages 51-55. doi:10.1002/nbm.927
Elizabeth R. Seaquist, Rolf Gruetter (1998): "Identification of a high concentration of scyllo-inositol in the brain of a healthy human subject using 1H- and 13C-NMR". Magnetic Resonance in Medicine, volume 39, issue 2, pages 313-316. doi:10.1002/mrm.1910390220
Yeong-Hau H. Lien, Thomas Michaelis, Rex A. Moats, Brian D. Ross (1994): "Scyllo-inositol depletion in hepatic encephalopathy". Life Sciences, volume 54, issue 20, pages 1507-1512 doi:10.1016/0024-3205(94)90018-3
Tarek Ibrahim, JoAnne McLaurin (2016): "α-Synuclein aggregation, seeding and inhibition by scyllo-inositol". Biochemical and Biophysical Research Communications, volume 469, issue 3, pages 529-534. doi:10.1016/j.bbrc.2015.12.043
M. Nozadze, E. Mikautadze, E. Lepsveridze, E. Mikeladze, N. Kuchiashvili, T. Kiguradze, M. Kikvidze, R. Solomonia (2011): "Anticonvulsant activities of myo-inositol and scyllo-inositol on pentylenetetrazol induced seizures". Seizure, Volume 20, Issue 2, March, Pages 173-176 doi:10.1016/j.seizure.2010.10.008
McLaurin, Joanne; Kierstead, Meredith E.; Brown, Mary E.; Hawkes, Cheryl A.; Lambermon, Mark H L.; Phinney, Amie L.; Darabie, Audrey A.; Cousins, Julian E.; French, Janet E.; Lan, Melissa F.; Chen, Fusheng; Wong, Sydney S N.; Mount, Howard T J.; Fraser, Paul E.; Westaway, David; George-Hyslop, Peter St (July 2006). "Cyclohexanehexol inhibitors of Abeta aggregation prevent and reverse Alzheimer phenotype in a mouse model". Nature Medicine. 12 (7): 801–8. doi:10.1038/nm1423. PMID16767098. S2CID24478093.
Daniela Fenili, Mary Brown, Rebecca Rappaport, JoAnne McLaurin (2007): "Properties of scyllo–inositol as a therapeutic treatment of AD-like pathology". Journal of Molecular Medicine, volume 85, pages 603–611. doi:10.1007/s00109-007-0156-7
Daniela Fenili, Keran Ma, JoAnne McLaurin (2010): "scyllo-Inositol: A potential therapeutic for Alzheimer's disease". Chapter 5 of Emerging Drugs and Targets for Alzheimer's Disease, Volume 1: Beta-Amyloid, Tau Protein and Glucose Metabolism, pages 94-116 doi:10.1039/9781849731065-00094
Ming Jin, Dennis J. Selkoe (2015): "Systematic analysis of time-dependent neural effects of soluble amyloid β oligomers in culture and in vivo: Prevention by scyllo-inositol". Neurobiology of Disease, volume 82, pages 152-163 doi:10.1016/j.nbd.2015.05.020
S. Salloway, R. Sperling, R. Keren, A.P. Porsteinsson, C.H. van Dyck, P.N. Tariot, S. Gilman, D. Arnold, S. Abushakra, C. Hernandez, G. Crans, E. Liang, G. Quinn, M. Bairu, A. Pastrak, and J.M. Cedarbaum (2011): "A phase 2 randomized trial of ELND005, scyllo-inositol, in mild to moderate Alzheimer disease" (ELND005-AD201 trial). Neurology, volume 77, issue 13, pages 1253-1262. Quote: "The primary efficacy analysis at 78 weeks revealed no significant differences between the treatment groups on the NTB or ADCS-ADL." doi:10.1212/WNL.0b013e3182309fa5
Michael S. Rafii, Brian G. Skotko, Mary Ellen McDonough, Margaret Pulsifer, Caseye Evans, Eric Doran, Gabriel Muranevici, Patrick Kesslak, Susan Abushakra, Ira T. Lott, for the ELND005-DS Study Group (2017): "A randomized, double-blind, placebo-controlled, Phase II study of oral ELND005 (scyllo-inositol) in young adults with Down syndrome without dementia". Journal of Alzheimer's Disease, volume 58, issue 2, pages 401-411 doi:10.3233/JAD-160965
